Conference Track

Hepatitis and Opportunistic Coinfections

Source: CCO Official Conference Coverage of the 2006 International AIDS Conference

Capsule Summaries

Decline in the Incidence of Community-Acquired Pneumonia in HIV-Infected Injection Drug Users During HAART Era
Growing Risk of CA-MRSA Infection in HIV-Infected Patients
Combination HAART and Isoniazid Prophylaxis Highly Effective at Reducing Tuberculosis Incidence in HIV-Infected Patients in Rio de Janeiro, Brazil
Cervical Cytological Abnormalities Found in Majority of HIV-Infected Zambian Women
Sharp Rise in Anal Malignancies Identified in French Hospitals Not Affected by HAART
HIV-Positive Patients Coinfected With Acute HCV Infection Show High SVR Rates After 24 Weeks of Peginterferon Plus Ribavirin
Factors Associated With Seronegative Chronic HCV Infection in Patients With HIV
PCP Prophylaxis Possibly Unnecessary When HIV-1 RNA Suppressed on HAART Even if CD4+ Cell Count < 200 cells/mm³
Extensively Drug-Resistant TB Common and Fatal Among HIV/TB-Coinfected Individuals in Rural South African Setting
Efavirenz-Based Regimens Potent in Treatment-Naive Individuals Over Wide Range of Baseline Viral Loads and CD4+ Cell Counts

Expert Analysis

Hepatitis and Opportunistic Coinfections

Faculty:

Richard E. Chaisson, MD
Bruce Polsky, MD
Jürgen K. Rockstroh, MD

Learning Objectives

Upon completion of this activity, participants should be able to:

Recount recent data regarding the impact of HAART and prophylaxis on the incidence of tuberculosis in HIV-infected patients
Discuss the incidence of coinfections such as Pneumocystis jiroveci pneumonia and community-acquired methicillin-resistant Staphylococcus aureus in HIV-infected patients and specific patient subgroups
Summarize new data on hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection in HIV-infected patients, including treatment of acute HCV and the impact of HBV treatment on cirrhosis
Describe the implications of coinfection with human papillomavirus for HIV-infected patients

CME CREDIT INFORMATION

Release Date: 09/29/06

Expiration Date: 09/28/07

Physicians: maximum of 1.5 AMA PRA Category 1 Credits™

Registered Nurses: 1.8 Nursing CE credits

Pharmacists: 1.5 contact hours (0.15 CEUs)

Status: Please log in to view status

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.